Jiang P, Chipurupalli S, Yoo B, Liu X, Rosen K
Cell Death Dis. 2025; 16(1):118.
PMID: 39979285
PMC: 11842741.
DOI: 10.1038/s41419-025-07436-z.
Shen S, Zhuang H
Medicine (Baltimore). 2024; 103(44):e40380.
PMID: 39496012
PMC: 11537654.
DOI: 10.1097/MD.0000000000040380.
Goleij P, Tabari M, Rezaee A, Sanaye P, Daglia M, Alijanzadeh D
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39476244
DOI: 10.1007/s00210-024-03540-7.
Pardo-Avila F, Kudva R, Levitt M, von Heijne G
bioRxiv. 2024; .
PMID: 39229094
PMC: 11370347.
DOI: 10.1101/2024.08.20.608737.
Yin Z, Yao Z, Chen D, Zhang Y, Weng G, Du X
J Cancer Res Clin Oncol. 2024; 150(7):336.
PMID: 38969948
PMC: 11226518.
DOI: 10.1007/s00432-024-05861-9.
Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia.
Suo S, Zhao D, Li F, Zhang Y, Rodriguez-Rodriguez S, Truong Nguyen L
Blood. 2024; 144(12):1343-1347.
PMID: 38968151
PMC: 11451333.
DOI: 10.1182/blood.2023023400.
Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia.
Yang L, Zhang Z, Jiang P, Kong D, Yu Z, Shi D
Nat Cell Biol. 2024; 26(6):946-961.
PMID: 38745030
DOI: 10.1038/s41556-024-01420-z.
Differential effects of translation inhibitors on liver stage parasites.
McLellan J, Hanson K
Life Sci Alliance. 2024; 7(6).
PMID: 38575357
PMC: 10994859.
DOI: 10.26508/lsa.202302540.
Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles.
Thomas J, Shelton 4th C, Murphy J, Brittain S, Bray M, Aspesi P
ACS Chem Biol. 2024; 19(4):938-952.
PMID: 38565185
PMC: 11040606.
DOI: 10.1021/acschembio.3c00737.
Translation inhibition efficacy does not determine the liver stage antiplasmodial efficacy of protein synthesis inhibitors.
McLellan J, Hanson K
bioRxiv. 2023; .
PMID: 38106175
PMC: 10723475.
DOI: 10.1101/2023.12.07.570699.
Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model.
Qiu X, Zhang H, Tang Z, Fan Y, Yuan W, Feng C
Chin Med J (Engl). 2023; 137(12):1453-1464.
PMID: 37962205
PMC: 11188914.
DOI: 10.1097/CM9.0000000000002813.
Single-cell quantitative bioimaging of liver stage translation.
McLellan J, Sausman W, Reers A, Bunnik E, Hanson K
mSphere. 2023; 8(6):e0054423.
PMID: 37909773
PMC: 10732057.
DOI: 10.1128/msphere.00544-23.
USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and cancer cell survival upon ribotoxic stress.
Qin K, Yu S, Liu Y, Guo R, Guo S, Fei J
Nat Commun. 2023; 14(1):6473.
PMID: 37833415
PMC: 10575996.
DOI: 10.1038/s41467-023-42257-8.
Structural conservation of antibiotic interaction with ribosomes.
Paternoga H, Crowe-McAuliffe C, Bock L, Koller T, Morici M, Beckert B
Nat Struct Mol Biol. 2023; 30(9):1380-1392.
PMID: 37550453
PMC: 10497419.
DOI: 10.1038/s41594-023-01047-y.
Synthetic and Semisynthetic Compounds as Antibacterials Targeting Virulence Traits in Resistant Strains: A Narrative Updated Review.
Stojkovic D, Petrovic J, Carevic T, Sokovic M, Liaras K
Antibiotics (Basel). 2023; 12(6).
PMID: 37370282
PMC: 10295040.
DOI: 10.3390/antibiotics12060963.
Quassinoid analogs exert potent antitumor activity via reversible protein biosynthesis inhibition in human colorectal cancer.
Wei N, Burnett J, Crocker D, Huang Y, Li S, Wipf P
Biochem Pharmacol. 2023; 212:115564.
PMID: 37116665
PMC: 11225567.
DOI: 10.1016/j.bcp.2023.115564.
Insights into translocation mechanism and ribosome evolution from cryo-EM structures of translocation intermediates of Giardia intestinalis.
Majumdar S, Emmerich A, Krakovka S, Mandava C, Svard S, Sanyal S
Nucleic Acids Res. 2023; 51(7):3436-3451.
PMID: 36912103
PMC: 10123126.
DOI: 10.1093/nar/gkad176.
Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel.
Plett R, Mellor P, Kendall S, Hammond S, Boulet A, Plaza K
Sci Rep. 2022; 12(1):15663.
PMID: 36123435
PMC: 9485251.
DOI: 10.1038/s41598-022-19621-7.
Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure.
Capelli D, Menotti D, Fiorentini A, Saraceni F, Olivieri A
Cancers (Basel). 2022; 14(17).
PMID: 36077850
PMC: 9454516.
DOI: 10.3390/cancers14174315.
A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers.
Regassa H, Sourirajan A, Kumar V, Pandey S, Kumar D, Dev K
Cancers (Basel). 2022; 14(16).
PMID: 36010892
PMC: 9406073.
DOI: 10.3390/cancers14163898.